Name: The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (Springerbriefs in Political Science) (en Inglés)
Price: 81130.00 CLP
Availability: InStock
Author: Elize Massard Da Fonseca
ISBN: 9783319125640

portada The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (Springerbriefs in Political Science) (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Elize Massard Da Fonseca

Año

2014

Idioma

Inglés

N° páginas

117

Encuadernación

Tapa Blanda

ISBN13

9783319125640

N° edición

2015

Categorías

Economía política

The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (Springerbriefs in Political Science) (en Inglés)

Elize Massard Da Fonseca (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 81.130

$ 135.210

Ahorras: $ 54.080

40% descuento

Cantidad
Estado: Nuevo
Quedan 100+ unidades

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 24 de Mayo y el Miércoles 05 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil (Springerbriefs in Political Science) (en Inglés)"

Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform’s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil, explores the following: · The politics of pharmaceutical regulation in Brazil over the last 25 years.· The political negotiations to approve the Generic Drug Act, which involved a hard-to-reach agreement between the pharmaceutical industry (national and multinational), the Ministry of Health, and Congress· The controversial decisions to regulate packaging and pharmaceutical equivalence.· The surprising success of Brazilian pharmaceutical firms, which became market champions in a sector largely dominated by multinational firms.· Comparative lessons from the Brazilian case for the political construction of regulatory standards to regulate generic drugs and its effects on global health. This book will interest political scientists and health policy scholars concerned with the political conflicts in the pharmaceutical sector. It argues against well-established approaches to regulatory capture such as control of the regulatory process by interest groups and policy diffusion. It can be used as evidence for graduate courses in public policy, health policy and political science. Because Brazil is one of the largest markets for pharmaceuticals in the world, business leaders and consultancy firms would also be interested.